Filing Details
- Accession Number:
- 0000899243-17-019943
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-09 17:16:25
- Reporting Period:
- 2017-08-07
- Filing Date:
- 2017-08-09
- Accepted Time:
- 2017-08-09 17:16:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1655816 | Joseph Lambing | C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-08-07 | 5,000 | $25.00 | 119,718 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-08-07 | 5,000 | $30.00 | 114,718 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-08-08 | 5,000 | $35.00 | 109,718 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.